Skip to main content
Erschienen in: Inflammation Research 2/2010

01.03.2010 | Short Communication

Histamine influence on apoptosis in trophoblast cell cultures

verfasst von: M. Pyzlak, G. Szewczyk, D. Szukiewicz, A. Szczesniak

Erschienen in: Inflammation Research | Sonderheft 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

It has been demonstrated that histamine plays an important role in the pathogenesis of preeclampsia. Histamine regulates the process of differentiation of trophoblast cells; it also acts as a growth factor in malignant melanoma cells, and prevents monocytic apoptosis. Trophoblast research has shown that in preeclampsia placentas, trophoblast apoptosis is significantly increased.

Aim of the study

The aim of our study was to demonstrate the influence of histamine on the process of apoptosis in human trophoblast cell cultures.

Materials and methods

Placentas were obtained after vaginal delivery. Tissue samples were excised from placentas and, with the use of modified Kliman’s method, trophoblast cell cultures were established. The cultures were incubated with dexamethasone as an apoptosis inducer 48 hours prior to apoptosis detection assays. Along with dexamethasone, selected cell cultures were incubated with histamine (1 μmol/l) or histamine (1 μmol/l) and terfenadine (from 1 to 5 μmol/l), a H1 receptor antagonist. For apoptotic activity detection, and quantitative analysis, we used an ELISA assay. M30‐Apoptosense ELISA Kit is based on the M30 monoclonal antibody that binds only the caspase‐cleaved cytokeratin 18 formed during apoptosis in trophoblast cells.

Results

Our investigation showed significantly (p < 0.05) increased apoptotic activity in cultures incubated with dexamethasone, histamine and terfenadine (% of reference value, ±SEM): up to 113.1 ± 4.33%. Cell cultures incubated with dexamethasone and histamine only showed significantly lower apoptotic activity 90.2 ± 5.17%. We suggest that histamine may inhibit apoptotic activity in trophoblast cell cultures via H1 receptor. Thus histamine may regulate the process of trophoblast differentiation (via integrin aV‐b3 expression, as we previously suggested), and influence cell turnover in the placenta.
Literatur
1.
Zurück zum Zitat Szukiewicz D, Szukiewicz A, Maslinska D, Markowski MW. Placental mast cells (MC) and histamine (HA) in pregnancy complicated by diabetes class C–relation to the development of villous microvessels. Trophoblast Res. 1999;13:503–10. Szukiewicz D, Szukiewicz A, Maslinska D, Markowski MW. Placental mast cells (MC) and histamine (HA) in pregnancy complicated by diabetes class C–relation to the development of villous microvessels. Trophoblast Res. 1999;13:503–10.
2.
Zurück zum Zitat Vicovac L, Jones CJP, Aplin JD. Trophoblast differentiation during formation of anchoring villi in a model of the early human placenta in vitro. Placenta. 1995;16:41–56.CrossRefPubMed Vicovac L, Jones CJP, Aplin JD. Trophoblast differentiation during formation of anchoring villi in a model of the early human placenta in vitro. Placenta. 1995;16:41–56.CrossRefPubMed
3.
Zurück zum Zitat Szewczyk G, Szukiewicz D, Klimkiewicz J, Pyzlak M, Szewczyk A, Krajewska K. Influence of histamine on the process of human trophoblast differentiation. Inflamm Res. 2005;54(Suppl 1):S78–9.CrossRefPubMed Szewczyk G, Szukiewicz D, Klimkiewicz J, Pyzlak M, Szewczyk A, Krajewska K. Influence of histamine on the process of human trophoblast differentiation. Inflamm Res. 2005;54(Suppl 1):S78–9.CrossRefPubMed
4.
Zurück zum Zitat Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, et al. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther. 2006;11:1472–3. Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, et al. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther. 2006;11:1472–3.
5.
Zurück zum Zitat Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF. Purification, characterization, and in vitro differentiation of cytotrofoblasts from human term placentae. Endocrinology. 1986;118:1567–82.CrossRefPubMed Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF. Purification, characterization, and in vitro differentiation of cytotrofoblasts from human term placentae. Endocrinology. 1986;118:1567–82.CrossRefPubMed
6.
Zurück zum Zitat Breuckmann F, Von Kobyletzki G, Avermaete A, Kreuter A, Mannherz HG, Altmeyer P. Apoptosis of human dermal endothelial cells as a potential side effect following therapeutic administration of UVA irradiation: preliminary results. Arch Dermatol Res. 2002;294:303–9.PubMed Breuckmann F, Von Kobyletzki G, Avermaete A, Kreuter A, Mannherz HG, Altmeyer P. Apoptosis of human dermal endothelial cells as a potential side effect following therapeutic administration of UVA irradiation: preliminary results. Arch Dermatol Res. 2002;294:303–9.PubMed
7.
Zurück zum Zitat Molina-Hernández A, Velasco I. Histamine affects cell proliferation, apoptosis and differentiation of cerebro cortical neural stem cells. Dev Biol. 2007;306:392–3.CrossRef Molina-Hernández A, Velasco I. Histamine affects cell proliferation, apoptosis and differentiation of cerebro cortical neural stem cells. Dev Biol. 2007;306:392–3.CrossRef
8.
Zurück zum Zitat Jangi SM, Ruiz-Larrea MB, Nicolau-Galmés F, Andollo N, Arroyo-Berdugo Y, Ortega-Martínez I, et al. Terefenadine–induced apoptosis in human melanoma cells is mediated through Ca2+ homoestasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis. 2008;29:500–9.CrossRefPubMed Jangi SM, Ruiz-Larrea MB, Nicolau-Galmés F, Andollo N, Arroyo-Berdugo Y, Ortega-Martínez I, et al. Terefenadine–induced apoptosis in human melanoma cells is mediated through Ca2+ homoestasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis. 2008;29:500–9.CrossRefPubMed
Metadaten
Titel
Histamine influence on apoptosis in trophoblast cell cultures
verfasst von
M. Pyzlak
G. Szewczyk
D. Szukiewicz
A. Szczesniak
Publikationsdatum
01.03.2010
Verlag
SP Birkhäuser Verlag Basel
Erschienen in
Inflammation Research / Ausgabe Sonderheft 2/2010
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-009-0133-4

Weitere Artikel der Sonderheft 2/2010

Inflammation Research 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.